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INTRODUCTION
Duodenal variceal bleeding is very rare in patients
with portal hypertension. Though re-bleeding or com-
plications are reported concerning non-surgical treat-
ments for ruptured duodenal varices (1-3), there appears
to be only been one reported balloon occluded retro-
grade transvenous obliteration (BRTO) with percu-
taneous transhepatic obliteration (PTO) for aduodenal
varix suggestive of bleeding with liver cirrhosis due
to hepatitis C virus infection (4).
In this report, we describe a case with ruptured duo-
denal varices, which appeared postoperatively following
multiple liver metastasis from rectal cancer, that was
successfully treated by BRTO combined with PTO.
CASE REPORT
A 39-year-old woman was admitted to our hospital
for melena and hematemesis. At age of 33, because
of rectal cancer with multiple liver metastasis she
had undergone low anterior resection of the rectum
and resection of the right hepatic lobe ; the upper part
of the medial segment and the superior area of lateral
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segment (Figure 1). The patient received oral tegafur/
uracil, and mitomycin-C via the hepatic artery as post-
operative adjuvant chemotherapy. She was relatively
well until the current hospitalization.
At admission, blood pressure was 88/50mmHg and
heart rate 106/min. There was no scleral jaundice.
Cardiopulmonary examination was unremarkable ex-
cept for tachycardia. Melena was evident on rectal ex-
amination. The initial hemoglobinwas7.7g/dl, platelet
count 68,000/mm3, albumin 3.0 g/dl, total bilirubin
0.8 mg/dl, aspartate aminotransferase 52U/L, alanine
aminotransferase 23U/L, blood urea nitrogen 24mg/dl,
and creatinine 0.42 mg/dl. The patient had no viral
hepatitis or immunoserologicalmarkers, nor anyhistory
of alcohol consumption.
Emergent esophagogastro-duodenoscopy revealed
no esophageal varices. A small amount of pooled blood
was recognized in the stomach ; beingsuperficial erosive
gastritis with oozing blood. Furthermore, duodenal
varices in the second portionwere detected (Figure2A).
A computed tomography examination showed a hy-
pertrophyic remnant lobe (Figure 3A) and marked
duodenal varices were located in the lumen of the duo-
denum (Figure 3B). No metastatic nodules were re-
vealed in the remnant liver.
Anemia progressed after admission, andesophagogastro-
duodenoscopy revealed duodenal varicesoozingblood.
Endoscopic variceal ligation (EVL)wasperformed for the
duodenal varices. Hematemesis andmelena appeared
13 days after the EVL, and a second EVLwas carried
out for the varices in the duodenal second portion be-
cause of re-bleeding. No hemorrhage fromtheduodenal
varices was recognized for 33 days after the secondEVL,
Fig.1． Preoperative computed tomography scan of the abdomen
reveals multiple liver metastasis, which occupy the greater part of
the liver.
Fig. 2．In the secondportion of the duodenum,
there are varices with stigmata oozing blood (A).
At day 19 after EVL, duodenal varices became
scarred and no bleeding is recognized (B). Re-
bleeding from stanched varices in the duodenal
second portion is recognized at 34 days after EVL
(C).
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and the duodenal wall became scarred (Figure 2B).
Hemorrhage from the stanchedvarices in the duodenal
second portion was recognized at the 34th day after
EVL (Figure 2C). AlthoughEVLwas carried out again
for the duodenal varices, hemostasiswasunsuccessful
becauseof thehard scar tissue formationafter the series
of EVLs ; as well, hepatic encephalopathy appeared.
Because the hemodynamics around the duodenal
varices were unclear using transarterial portography
and a sclerosing agent might have leaked into the
systemic circulation or the portal vein via themultiple
drainage or feeding vessels of the duodenal varices,
percutaneous transhepatic portography (PTP) was
performed via the portal branch of the hypertrophied
caudate lobe using an abdominal ultrasonographic
guide. The duodenal varices originated in the portal
vein via some afferent vessels and drained into the ef-
ferent vein (Figure 4A). There was neither oppressive,
stenotic, no blocking image in the portal vein. Portal
vein pressure was 30 cmH2O. A 5-Fr balloon catheter
(MOIYAN,GOODTEC,Gifu, Japan) was inserted into
the drainage vein through the right femoral vein accord-
ing to the Seldinger technique. The efferent vein (di-
ameter 6 mm) drained directly into the inferior vena
cava, located a little to the cranial side of a right renal
vein (Figure 4B). Using retrograde transvenousvenog-
raphy, the efferent vessels were revealed inmore detail
thanwithPTP.However, retrograde transvenous venog-
raphy did not reveal the afferent vessels of theduodenal
varices. To effectively pool the sclerosing agent in
Fig. 3．Computed tomography scan of the abdomen reveals markedly hypertrophic remnant liver (the caudate and part
of left lobes), a low density area as a postoperative change in the lateral segment, and the inferior vena cava displaced
on the right side. Collateral vessels and portosystemic shunt via the duodenal varices are observed (white arrows) (A).
Contrast enhanced duodenal varices are located in the lumen of the duodenum (white arrow) (B).
Fig. 4．Percutaneous transhepatic portography (PTP) was performed via the portal vein branch of the caudate lobe, which
was obviously hypertrophied due to an operation. The afferent vessels (black arrow) from the portal vein form varices
(black arrow head), and drain into the efferent vein (white arrow) (A). Using retrograde transvenous venography, the
duodenal varices (black arrow head) and the efferent vein (white arrow) are shown to directly drain into the inferior vena
cava (white arrow head) ; and in more detail than using PTP (B).
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the entire portosystemic shunt, PTO was initially car-
ried out. A microcatheter (Progreat Micro Catheter,
TERUMO, Tokyo, Japan) was advanced into these
afferent vessels to perform microcoil occlusion. Mi-
crocoils (TORNADOEMBOLIZATIONMICROCOIL,
COOK, Bloomington, Minnesota, USA) were placed
in the afferent vessels (Figure 5A). Next, balloon oc-
cluded retrograde transvenous venography was per-
formed to confirm that the contrast medium had not
leaked out of the estimated area and tobetter ascertain
the right amount of sclerosing agent to use for oblit-
eration. Using a microcatheter, 5% ethanolamine oleate
with iopamidol (total volume, 4.0ml) was injected into
the portosystemic shunt. The sclerosing agent had not
leaked out of the estimated area (Figure 5A), and
the balloon was inflated for 24h to completely pool the
sclerosing agent. Twenty-four hours after treatment,
balloon occluded retrograde transvenous venography
was performed to confirm complete hemostasis and
to assess whether therewere anynewefferent vessels ;
this showed that the contrast medium had not com-
pletely flowed into thevessels.By retrograde transvenous
venography (collapsed balloon), only part of the afferent
vessels were imaged retrogradely (Figure 5B). Labo-
ratory data on the 4th post-treatment day indicated
that the range of the ammonia was lowered from 161
µg/dl to 48 µg/dl (normal range, 12-66µg/dl).Grade II
hepatic encephalopathy was also disappeared. No re-
bleeding episode has been observed since treatment.
However, the patient died of a metastatic brain tumor
11weeks after BRTOwith PTO for theduodenal varices.
DISCUSSION
The etiology of the duodenal varices ismostly portal
hypertension due to cirrhosis, idiopathic portal hy-
pertension, or extra hepatic portal obstruction (5).
Although temporary portal hypertension after hepatec-
tomy is reported (6), no report on permanent portal
hypertension was found. After surgery for rectal can-
cer with hepatic metastasis, our patient received 400
mg of oral UFT○R daily and administration of 6 mg of
mitomycin-C 6weekly via the hepatic artery as postop-
erative adjuvant chemotherapy.Chronic activehepatitis
and liver cirrhosis induced by the combination of tega-
fur and tamoxifen (7) or by UFT○R alone(8,9)havebeen
reported. Functional abnormalities of the liver have
occasionally been reported following normal doses of
mitomycin-C; and large doses of mitomycin-C induce
veno-occlusive disease or hepatitis (10). Harmful side
effects can result in liver cirrhosis ; whichmight occur
in the period in which there is cell division after he-
patectomy using anticancer drugs.
There are case reports concerning ruptured duo-
denal varix successfully managed by EVL (11) and
successful BRTO for re-bleeding fromduodenal varices
after EVL (2). Endoscopic variceal sclerotherapy (EIS)
with thrombin, polidocanol, ethanolamine oleate, so-
dium tetradecyl sulfate, and n-butyl-2-cyanoacrylate,
andα-cyanoacrylate asprimary care in the hemorrhage
from duodenal varices is reported (12-14). For bleeding
esophageal varices, a few randomized controlled trials
that compared EIS with EVL, have favored EVL for
Fig. 5．Microcoils were placed in the afferent vessels (black arrows) via the efferent vein, 4 ml of 5% ethanolamine oleate
with iopamidol was injected under superselective catheterization into duodenal varices (black arrow head) (A). Retrograde
transvenous venography at 24 h after treatment revealed that duodenal varices were not imaged (black arrow head)
and no newly efferent vessels were found (B).
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decreasing the risk of re-bleeding with fewer compli-
cations (15 -18). Further, urgent endoscopic examina-
tion is indispensable when uppergastrointestinal bleed-
ing is suspected. Therefore, EVL seems to be a first
choice, but a randomized controlled trial would be nec-
essary to establish a therapy for duodenal varices. For
repeatedhemorrhage in spite of a seriesofEVL,another
treatment should be chosen.
While carrying out this procedure, there is some
possibility of complications, such as renal dysfunction,
pulmonary embolism,pleural effusion, pulmonary edema,
hypertensitivity reaction, and pyrexia. It is important
to prevent the sclerosing agent had not leaked out of
the estimate area. Ethanolamine oleate promptly binds
with albumin in the blood, thus becoming inactive, and
decomposes. It is necessary to revisehypoalbuminemia
in advance. Ethanolamine oleate also causeshemolysis
of the blood vessels, leading free hemoglobin, which
may give rise renal dysfunction. Intravenous admini-
stration of haptoglobin, which combines with free he-
moglobin prevents renal dysfunction associated with
hemolysis.
PTP was performed because the hemodynamics
around the duodenal varices were unclear from tran-
sarterial portography, and it is possible that the scle-
rosing agent might have leaked into the systemic cir-
culation or a portal vein via the multiple drainage or
feeding vessels of the duodenal varices. In this case,
PTP could reveal the detailed hemodynamics. Follow-
ing PTO, the sclerosing agent had not leaked into the
systemic circulation or portal vein via themultiple drain-
age or feeding vessels of the duodenal varices, which
appeared stagnatedbyBRTO.Hepatic encephalopathy
also improved. There were no complications afterPTO,
andBRTO. For duodenal varices, thismethodbywhich
afferent and efferent vessels including varices are em-
bolized, is an excellent therapy from the viewpoints
of safety and certainty.
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